Eisai, NCC Strike Drug Discovery Deal on Rare/Refractory Cancers

May 17, 2021
Eisai and the National Cancer Center said on May 14 that they have launched collaborative research on the discovery of new therapeutic drugs to treat rare cancers and refractory cancers with high unmet medical needs. To discover drugs for these...read more